\"Alcohol-associated liver disease: integrated management with alcohol use disorder\". - Université de Lille Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Clinical Gastroenterology and Hepatology Année : 2023

\"Alcohol-associated liver disease: integrated management with alcohol use disorder\".


Alcohol-associated liver disease (ALD) is the most common cause of cirrhosis and liver-related mortality in many regions worldwide. Around 75% of patients with cirrhosis are unaware of their disease until they are referred to the emergency department. An innovative, noninvasive screening approach is required for an earlier diagnosis of liver fibrosis. In patients with ALD the physician is inevitably dealing with 2 major disorders: the liver disease itself and the alcohol use disorder (AUD). Focus only on the liver disease will inevitably lead to failure because transient improvements in liver function are rapidly overturned if the patient returns to alcohol consumption. For this reason, integrated models of care provided by hepatologists and addiction specialists are an effective approach, which are, however, not widely available. There are multiple pharmacologic and non-pharmacologic therapies for AUD. Progress has recently been made in the management of patients with severe AH who have improved survival through better understanding of the concept of response to medical treatment, improved survival prediction, and the advent of early liver transplantation. The emerging concept is that listing for transplantation a patient with severe ALD could lead to adjusting the duration of abstinence according to the severity and evolution of liver dysfunction and the patient’s addictive profile.

Dates et versions

hal-04521365 , version 1 (26-03-2024)



Juan P. Arab, Giovanni Addolorato, Philippe Mathurin, Mark R. Thursz. \"Alcohol-associated liver disease: integrated management with alcohol use disorder\".. Clinical Gastroenterology and Hepatology, 2023, Clinical Gastroenterology and Hepatology, ⟨10.1016/j.cgh.2023.02.017⟩. ⟨hal-04521365⟩


4 Consultations
0 Téléchargements



Gmail Mastodon Facebook X LinkedIn More